HOME/ABOUT  Prayer  SCOTUS  ProLife  BangList  Aliens  StatesRights  ConventionOfStates  WOT  HomosexualAgenda  GlobalWarming  Corruption  Taxes  Congress  Fraud  MediaBias  GovtAbuse  Tyranny  Obama  ObamaCare  Elections  Polls  Debates  Trump  Carson  Cruz  Bush  OPSEC  Benghazi  InfoSec  BigBrother  IRS  Scandals  TalkRadio  TeaParty  FreeperBookClub  HTMLSandbox  FReeperEd  FReepathon  CopyrightList  Copyright/DMCA Notice 

Working on the last $8k! Let's get 'er done! Thank you very much for your loyal support, Jim

Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794
Free Republic 4th Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $79,674
Woo hoo!! And now less than $8.4k to go!! Thank you all very much!!

Keyword: antibioticdrugs

Brevity: Headers | « Text »
  • New antibiotics: what's the hold up?

    03/19/2013 9:19:09 PM PDT · by neverdem · 2 replies
    Chemistry World ^ | 6 March 2013 | Derek Lowe
    If you’re an editor in need of a medical headline to fill out some column space, I can recommend ‘New antibiotics needed, experts warn’. Don’t worry if you don’t have all the details: experts are always warning about that, and unfortunately, they’re always right. That headline’s been valid for years now, and it looks like it will be good for quite a few more.Now, why should that be? Here’s a large market, with a substantial unmet need that’s doing nothing but growing over time. Why aren’t the pharma research labs stepping up to fill it? You can get several answers...
  • Antibiotic resistance is a ‘ticking time bomb’

    03/19/2013 8:48:16 PM PDT · by neverdem · 16 replies
    Chemistry World ^ | 13 March 2013 | Ned Stafford
    MRSA is one of a number of bacteria that are resistant to many antibiotics © Science Photo LibraryGlobal research efforts to develop new antibiotics need to be accelerated urgently, the UK government’s chief medical officer has warned. She adds that that new drugs are desperately needed to fight the ‘catastrophic threat’ of growing antimicrobial resistance.In the second part of her annual report Dame Sally Davies focuses on antimicrobial resistance and infectious diseases. She says that the development of new antibiotics has stalled since the late 1980s because ‘there are fewer economic incentives’ to produce new antimicrobial agents than for other...